For Joshua, and for the 200,000 other young people with Type 1 diabetes, let's cap the cost of insulin at $35 a month so everyone can afford it. And drug companies will do very, very well - their profit margins.  And while we're at it, let's let Medicare negotiate the price of prescription drugs.